M. Wauben

发表

Extending gene ontology in the context of extracellular RNA and vesicle communication

Kei-Hoi Cheung, Andrew I. Su, Kasey Vickers, 2016, Journal of biomedical semantics.

Notochordal-cell derived extracellular vesicles exert regenerative effects on canine and human nucleus pulposus cells

Keita Ito, Marianna Tryfonidou, B. Meij, 2017, Oncotarget.

Truncation of the neuritogenic peptide bP2(60–70) results in the generation of altered peptide ligands with the potential to interfere with T cell activation

R. Gold, A. Weishaupt, K. Toyka, 2002, Journal of Neuroimmunology.

Competition for antigenic sites during T cell proliferation: a mathematical interpretation of in vitro data.

J. Borghans, R. D. de Boer, M. Wauben, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis.

M. Wauben, R. Schiffelers, G. Molema, 2006, Arthritis and rheumatism.

Flow cytometric analysis of extracellular vesicle subsets in plasma: impact of swarm by particles of non‐interest

M. Wauben, E. N. Nolte-‘t Hoen, M. Wauben, 2018, Journal of thrombosis and haemostasis : JTH.

Immunomodulatory effects of antigen-pulsed macrophages in a murine model of allergic asthma.

W. van Eden, M. Wauben, E. Janssen, 2002, American journal of respiratory cell and molecular biology.

The Efficacy of Immunotherapy in an Experimental Murine Model of Allergic Asthma Is Related to the Strength and Site of T Cell Activation During Immunotherapy1

W. van Eden, M. Wauben, E. Janssen, 2000, The Journal of Immunology.

PeptideSkewing Characteristics of the Therapeutic Disease Process Depends on the Th1 or Th2 Asthma: Amelioration or Deterioration of the Analogues in a Murine Model of Allergic Modulation of Th2 Responses by Peptide

M. Wauben, E. Janssen, W. Eden, 1999 .

Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.

M. Wauben, R. Liskamp, E. Moret, 2005, Molecular immunology.

Artificial antigen-presenting cells as a tool to exploit the immune `synapse'

M. Wauben, S. Albani, B. Prakken, 2000, Nature Medicine.

Endosomally Stored MHC Class II Does Not Contribute to Antigen Presentation by Dendritic Cells at Inflammatory Conditions

M. Wauben, W. Stoorvogel, M. Wauben, 2011, Traffic.

'Anergic' T cells modulate the T-cell activating capacity of antigen-presenting cells.

W. van Eden, M. Wauben, M. Wauben, 2000, Journal of autoimmunity.

CD4 rat × rat and mouse × rat T cell hybridomas produced by fusion of established T cell lines and clones to W/Fu (C58NT)D

W. van Eden, M. Wauben, P. V. van Kooten, 1991, Journal of Immunological Methods.

Trafficking of MHC Class II in Dendritic Cells is Dependent on but Not Regulated by Degradation of Its Associated Invariant Chain

M. Wauben, W. Stoorvogel, M. Wauben, 2010, Traffic.

Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles

Jennifer C. Jones, L. O’Driscoll, Lesley Cheng, 2019, Journal of extracellular vesicles.

MHC class II (RT1.Bl) binding capacity of autoimmune disease-related T-cell determinants and their sequence analogues in the Lewis rat.

S. Buus, W. van Eden, M. Wauben, 1993, Transplantation proceedings.

Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases?

W. van Eden, M. Wauben, B. Prakken, 1998, Immunology today.

Major histocompatibility binding peptides: an experimental approach towards specific immunotherapy of autoimmune diseases

M. Wauben, W. Eden, 1994 .

Extending gene ontology in the context of extracellular RNA and vesicle communication

M. Gerstein, D. Galas, A. Su, 2016, Journal of biomedical semantics.

Peptoid-Peptide Hybrids: Design, Synthesis and MHC Binding

M. Wauben, R. Liskamp, J. Kruijtzer, 2001 .

Stabilization of peptide guinea pig myelin basic protein 72-85 by N-terminal acetylation-implications for immunological studies.

M. Wauben, R. Liskamp, D. Rijkers, 2004, Molecular immunology.

Heat shock protein 60 and adjuvant arthritis: a model for T cell regulation in human arthritis

M. Wauben, S. Albani, B. Prakken, 2003, Springer Seminars in Immunopathology.

Immune System during Experimental Arthritis Matrix Metalloproteinases as Targets for the

M. Wauben, W. Eden, M. Dijk, 2011 .

Matrix Metalloproteinases as Targets for the Immune System during Experimental Arthritis1

W. van Eden, M. Wauben, J. V. van Bilsen, 2004, The Journal of Immunology.

Arthritis Immune System during Experimental Matrix Metalloproteinases as Targets for the

M. Wauben, W. Eden, M. Dijk, 2004 .

Anergic T cells as active regulators of the immune response.

M. Wauben, M. Wauben, L. Taams, 2000, Human immunology.

CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis

W. van Eden, M. Wauben, G. Koning, 2005, Arthritis research & therapy.

Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen‐specific T cell responses without additional stimulation

W. van Eden, M. Wauben, E. N. Nolte-‘t Hoen, 2004, European journal of immunology.

Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134

M. Wauben, E. N. Nolte-‘t Hoen, G. Arkesteijn, 2008, Journal of leukocyte biology.

Anergic T cells actively suppress T cell responses via the antigen‐presenting cell

W. van Eden, M. Wauben, M. Poelen, 1998, European journal of immunology.

Synovial fluid pretreatment with hyaluronidase facilitates isolation of CD44+ extracellular vesicles

P. R. van Weeren, J. Malda, M. Wauben, 2016, Journal of extracellular vesicles.

Searching for the Cartilage-associated Mimicry Epitope in Adjuvant Arthritis

W. van Eden, M. Wauben, J. V. van Bilsen, 2002, Autoimmunity.

Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma.

W. van Eden, M. Wauben, E. Janssen, 1999, American journal of respiratory cell and molecular biology.

Induction of T Cell Anergy by Liposomes with Incorporated Major Histocompatibility Complex (MHC) II/Peptide Complexes

W. van Eden, M. Wauben, D. Crommelin, 2000, Pharmaceutical Research.

Liposomes with Incorporated MHC Class Il/Peptide Complexes as Antigen Presenting Vesicles for Specific T Cell Activation

W. van Eden, M. Wauben, D. Crommelin, 1999, Pharmaceutical Research.

Uptake of membrane molecules from T cells endows antigen‐presenting cells with novel functional properties

W. van Eden, P. Peters, M. Wauben, 2004, European journal of immunology.

Inhibition of Autoimmune T cells by “Competitor-Modulator” peptides

M. Wauben, C. Boog, W. Eden, 1993 .

Antigen presentation by T cells versus professional antigen‐presenting cells (APC): differential consequences for T cell activation and subsequent T cell‐APC interactions

W. van Eden, M. Wauben, L. Taams, 1999, European journal of immunology.

T cell reactivity to an epitope of the mycobacterial 65‐kDa heat‐shock protein (hsp 65) corresponds with arthritis susceptibility in rats and is regulated by hsp 65‐specific cellular responses

W. van Eden, M. Wauben, C. Boog, 1991, European journal of immunology.

Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.

W. van Eden, M. Wauben, S. Albani, 2002, Arthritis and rheumatism.

Nasal application of a naturally processed and presented T cell epitope derived from TCR AV11 protects against adjuvant arthritis.

W. van Eden, M. Wauben, A. Noordzij, 2000, International immunology.

Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy.

W. van Eden, M. Wauben, L. Taams, 1999, Journal of immunology.

Nasal administration of arthritis-related T cell epitopes of heat shock protein 60 as a promising way for immunotherapy in chronic arthritis

W. Kuis, M. Wauben, B. Prakken, 1998, Biotherapy.

Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone

Angelique T. E. F. Schlief, W. van Eden, M. Wauben, 1992, Journal of Experimental Medicine.

T Cell Reactivity to Heat Shock Protein 60 in Diabetes-Susceptible and Genetically Protected Nonobese Diabetic Mice Is Associated with a Protective Cytokine Profile1

A. Cooke, W. van Eden, M. Wauben, 2000, The Journal of Immunology.

Differential rat T cell recognition of cathepsin D-released fragments of mycobacterial 65 kDa heat-shock protein after immunization with either the recombinant protein or whole mycobacteria.

M. Wauben, C. Boog, S. Anderton, 1994, International immunology.

Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules

S. Buus, W. van Eden, L. Pedersen, 1994, International immunology.

Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response

W. van Eden, M. Wauben, M. D. de Baets, 1996, European journal of immunology.

Associated with a Protective Cytokine Profile Protected Nonobese Diabetic Mice Is Diabetes-Susceptible and Genetically T Cell Reactivity to Heat Shock Protein 60 in

A. Cooke, M. Wauben, B. Roep, 2000 .

(Altered) Self Peptides and the Regulation of Self Reactivity in the Peripheral T cell Pool

M. Wauben, B. Prakken, S. Anderton, 1996, Immunological reviews.

Adjuvant Arthritis in the Rat

W. van Eden, M. Wauben, J. Wagenaar-Hilbers, 1996, Current protocols in immunology.

Successful immunotherapy with matrix metalloproteinase-derived peptides in adjuvant arthritis depends on the timing of peptide administration

W. van Eden, M. Wauben, J. V. van Bilsen, 2002, Arthritis research.

Identification of self-epitopes recognized by T cells in rheumatoid arthritis demonstrates matrix metalloproteinases as a novel T cell target.

M. Wauben, J. Bijlsma, J. V. van Bilsen, 2003, The Journal of rheumatology.

Effector and regulatory T cells derived from the same T cell clone differ in MHC class II‐peptide multimer binding

W. van Eden, M. Wauben, E. N. Nolte-‘t Hoen, 2004, European journal of immunology.

Activated rat T cells synthesize and express functional major histocompatibility class II antigens.

W. van Eden, M. Wauben, M. Lucassen, 1995, Immunology.

Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide.

W. van Eden, M. Wauben, I. Joosten, 1994, Journal of immunology.

Towards peptide immunotherapy in rheumatoid arthritis: competitor-modulator concept.

W. van Eden, M. Wauben, C. Boog, 1992, Journal of autoimmunity.

Coimmunization of MHC Class II Competitor Peptides during Experimental Autoimmune Myasthenia Gravis Induction Resulted Not Only in a Suppressed, but Also in an Altered Immune Response a

M. Wauben, W. Eden, J. Wagenaar, 1998, Annals of the New York Academy of Sciences.

Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

Andrew F. Hill, Bernd Giebel, André Görgens, 2015, Journal of extracellular vesicles.

Improved Flow Cytometric Light Scatter Detection of Submicron‐Sized Particles by Reduction of Optical Background Signals

M. Wauben, G. Arkesteijn, S. Libregts, 2020, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Abundantly Present miRNAs in Milk-Derived Extracellular Vesicles Are Conserved Between Mammals

Basten L. Snoek, B. Snoek, C. Pieterse, 2018, Front. Nutr..

Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication

H. D. del Portillo, K. Riesbeck, M. Wauben, 2017, Journal of extracellular vesicles.

Concise Review: Developing Best‐Practice Models for the Therapeutic Use of Extracellular Vesicles

Bernd Giebel, Hidetoshi Tahara, Jan Lötvall, 2017, Stem cells translational medicine.

Augmented COlorimetric NANoplasmonic (CONAN) Method for Grading Purity and Determine Concentration of EV Microliter Volume Solutions

M. Wauben, A. Radeghieri, P. Nejsum, 2020, Frontiers in Bioengineering and Biotechnology.

Beneficial effect of modified peptide inhibitor of α4 integrins on experimental allergic encephalomyelitis in Lewis rats

M. Wauben, T. Kuijpers, M. Elices, 2002, Journal of neuroscience research.

Critical requirement for aspartic acid at position 82 of myelin basic protein 73-86 for recruitment of V beta 8.2+ T cells and encephalitogenicity in the Lewis rat.

M. Wauben, R. Smeltz, N. Wolf, 1999, Journal of immunology.

Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017

Jennifer C. Jones, James Brian Byrd, C. Compton, 2018, Journal of extracellular vesicles.

Immunogenicity of a mycobacterial T-cell epitope expressed in outer membrane protein PhoE of Escherichia coli.

J. Tommassen, M. Wauben, R. Janssen, 1994, Vaccine.

The launch of Journal of Extracellular Vesicles (JEV), the official journal of the International Society for Extracellular Vesicles – about microvesicles, exosomes, ectosomes and other extracellular vesicles

J. Lötvall, X. Breakefield, C. Théry, 2012, Journal of extracellular vesicles.

Genetic manipulation of major P-fimbrial subunits and consequences for formation of fimbriae

M. Wauben, P. Pouwels, H. Bergmans, 1988, Journal of bacteriology.

Encephalitogenicity in the Lewis Rat T Cells and + 8.2 b Recruitment of V 86 for - Position 82 of Myelin Basic Protein 73 Critical Requirement for Aspartic Acid at

M. Wauben, R. Smeltz, N. Wolf, 1998 .

Inhibition of entire myelin basic protein‐induced experimental autoimmune encephalomyelitis in Lewis rats by major histocompatibility complex class II‐binding competitor peptides

Angelique T. E. F. Schlief, W. van Eden, M. Wauben, 1994, European journal of immunology.

Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey

A. Hill, C. Théry, M. Wauben, 2016, Journal of extracellular vesicles.

Regular Industrial Processing of Bovine Milk Impacts the Integrity and Molecular Composition of Extracellular Vesicles.

M. Wauben, S. Libregts, A. Feitsma, 2021, The Journal of nutrition.

Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.

M. Wauben, R. Liskamp, E. Moret, 2005, Molecular immunology.

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

Jing Xu, Antonella Bongiovanni, Wilfrid Boireau, 2018, Journal of Extracellular Vesicles.

Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics

Raymond M. Schiffelers, Enrico Mastrobattista, M. Wauben, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Standardization of sample collection, isolation and analysis methods in extracellular vesicle research

Lynne T. Bemis, Edit I. Buzás, Kenneth W. Witwer, 2013, Journal of extracellular vesicles.

MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments

Romaric Lacroix, Joshua A. Welsh, Edwin Van Der Pol, 2020, Journal of extracellular vesicles.

Major histocompatibility complex class II binding characteristics of peptoid-peptide hybrids.

M. Wauben, R. Liskamp, J. Kruijtzer, 2002, Bioorganic & medicinal chemistry.

Cross-reactive mycobacterial and self hsp60 epitope recognition in I-A(g7) expressing NOD, NOD-asp and Biozzi AB/H mice.

A. Cooke, W. van Eden, M. Wauben, 2002, Journal of autoimmunity.

Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles

Andrew F. Hill, Susmita Sahoo, Edit I. Buzás, 2014, Journal of extracellular vesicles.

Biological membranes in EV biogenesis, stability, uptake, and cargo transfer: an ISEV position paper arising from the ISEV membranes and EVs workshop

S. Bhattacharyya, R. Vandenbroucke, M. Wauben, 2019, Journal of extracellular vesicles.

MISEV 2018 ) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV 2014 guidelines

Scott M Langevin, Valentina R Minciacchi, Morsi S Rayyan, 2018 .

Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop

P Poncelet, R Lacroix, F Dignat-George, 2017, Journal of thrombosis and haemostasis : JTH.

Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility

Alissa M. Weaver, S. Mathivanan, J. Lötvall, 2017, Journal of extracellular vesicles.

A novel community driven software for functional enrichment analysis of extracellular vesicles data

Pedro Fonseca, Ching-Seng Ang, David Chisanga, 2017, Journal of extracellular vesicles.

Announcing the ISEV2020 special achievement award recipients: Andrew Hill and Edit Buzás; and the recipient of the ISEV2020 special education award: Carolina Soekmadji

Alissa M. Weaver, M. Wauben, L. Languino, 2020, Journal of extracellular vesicles.

AFM-based High-Throughput Nanomechanical Screening of Single Extracellular Vesicles.

M. Brucale, M. Wauben, P. Nejsum, 2020, Analytical chemistry.

Cancer-ID: Toward Identification of Cancer by Tumor-Derived Extracellular Vesicles in Blood

R. Schasfoort, W. Roos, G. Jenster, 2020, Frontiers in Oncology.

AFM-based High-Throughput Nanomechanical Screening of Single Extracellular Vesicles

M. Brucale, M. Wauben, P. Nejsum, 2019, bioRxiv.

Towards mechanisms and standardization in extracellular vesicle and extracellular RNA studies: results of a worldwide survey

J. Lötvall, A. Hill, M. Wauben, 2018, Journal of extracellular vesicles.

Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice

J. Falkenburg, M. Wauben, L. Hambach, 2006, Leukemia.

Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients

D. de Jong, A. van den Berg, M. Wauben, 2016, JCI insight.

Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health

S. Kamphuis, W. Kuis, M. Wauben, 2006, Arthritis research & therapy.

Heat-Shock Proteins and Mycobacterial Antigens

M. Wauben, C. Boog, J. Embden, 1992 .

Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.BL molecule.

M. Wauben, I. Joosten, I Joosten, 1997, International immunology.

The role of extracellular vesicles when innate meets adaptive

M. Wauben, E. D. de Jong, T. Groot Kormelink, 2018, Seminars in Immunopathology.

Modulation of Th2 Responses by Peptide Analogues in a Murine Model of Allergic Asthma: Amelioration or Deterioration of the Disease Process Depends on the Th1 or Th2 Skewing Characteristics of the Therapeutic Peptide1

W. van Eden, M. Wauben, E. Janssen, 2000, The Journal of Immunology.

Identification of the immunodominant CTL epitope of EGFP in C57BL/6 mice

M. Wauben, Marca H.M. Wauben, W. Unger, 2008, Gene Therapy.

Distinct lipid compositions of two types of human prostasomes

J. W. Jansen, J. Brouwers, J. Helms, 2013, Proteomics.

Heat‐shock protein T‐cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T‐cell response

M. Wauben, W. Eden, R. Zee, 1998, Immunological reviews.

Tetraspanin-decorated extracellular vesicle-mimetics as a novel adaptable reference material

M. Yáñez-Mó, M. Wauben, H. Reyburn, 2019, Journal of extracellular vesicles.

Chapter 13 – Adjuvant Arthritis

M. Wauben, W. Eden, J. Wagenaar-Hilbers, 1994 .

Scientific Program 2012 ISEV meeting Wednesday 18th April

J. Lötvall, C. Théry, M. Wauben, 2012 .

Influence of amino acids of a carrier protein flanking an inserted T cell determinant on T cell stimulation.

J. Tommassen, M. Wauben, M. de Gast, 1994, International immunology.

Liposomes in autoimmune diseases: selected applications in immunotherapy and inflammation detection.

D. Crommelin, M. Wauben, G. Storm, 1999, Journal of controlled release : official journal of the Controlled Release Society.

Corrigendum: Augmented COlorimetric NANoplasmonic (CONAN) Method for Grading Purity and Determine Concentration of EV Microliter Volume Solutions

M. Wauben, A. Radeghieri, P. Nejsum, 2021, Frontiers in Bioengineering and Biotechnology.

Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics

M. Wauben, E. N. Nolte-‘t Hoen, R. Schiffelers, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Regulatory T cells in inflammation

M. Wauben, A. Akbar, L. Taams, 2005 .

Quaternary structure of a carrier protein influences antigenicity and immunogenicity of an inserted T cell determinant.

J. Tommassen, M. Wauben, R. Janssen, 1996, International immunology.

A peptide variant of an arthritis-related T cell epitope induces T cells that recognize this epitope as a synthetic peptide but not in its naturally processed form.

W. van Eden, M. Wauben, I. Joosten, 1993, Journal of immunology.